mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.8 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
skepinone-L |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.8 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.8 |